EKO International (EKNL) - Monster Attack Jumping 115% Today

Belize City, Belize -- (SBWIRE) -- 09/26/2012 -- Publishers of daily penny stock newsletter xtremepicks (http://www.xtremepicks.com) looks at EKO International (OTC:EKNL)

EKNL hit the ground running hard soaring 115% to close at $0.086 on the backs of MAJOR news issued by the company early this morning.

EKO International Corp – Distribution of Frequency Rhythmic Electrical Modulation Systems PR Newswire(Tue 9:45AM EDT)

EKO INTERNATIONAL INC. (EKO) - EKNL- Pinksheets -- is pleased to announce that oeBin Ltd., of Burlington, ON, has been engaged by NeuroVasc Clinical Inc.(NCI), (a joint venture company owed 51 % by NeuroVasc Medical Inc.(NVMI) and 49% by EKO.), as NCI's sole distributor representative for FREMS equipment in the states of New York and Florida.

FREMS (Frequency Rhythmic Electrical Modulation System) equipment is used in the treatment of Peripheral Neuropathy (damage to nerves in extremities such as lower legs and feet causing an interruption in communication between the brain and parts of the body with damaged nerves).

With over 60 million diabetics in North America and 60% of them suffering from Peripheral Neuropathy, the need for this treatment is overwhelming.

Further news is expected to be released in the immediate future in respect of FREMS and EKO's involvement with the technology and expected corporate earnings as a result.

In order to clarify the present state of shareholdings in EKO, the company wishes to confirm that it fully complied with the April Order by the Chancery Court of Delaware to issue 2,926,224 free trading shares of EKO, bringing the number of issued and outstanding shares as of the date of this release from 28,756,746 to 31,682,970 and the current float of free trading shares as of the date of this release to 8,079,427.

EKO will be issuing a further 1,000,000 restricted shares to NeuroVasc Medical Inc. in consideration for EKO's participation in the NCI Joint venture which holds the exclusive rights to market FREMS equipment.

FREMS is becoming one of the most sought after product that not only meets rigorous standards safety, but is approved as “safe and effective’ by the FDA!!!

So what is FREMS?

FREMS (Frequency Rhythmic Electrical Modulation System) delivers computer-controlled varied frequencies of electricity through electrodes placed on your skin to stimulate your nerves and blood vessels. Quality research studies have shown that not only are the nerves stimulated to work better (making you feel better), but the small blood vessels so often affected in diabetes, improve their circulation (making you safer and healthier!).

With over 60 million diabetics in North America and 60% of them suffering from Peripheral Neuropathy, the need for this treatment is overwhelming. With millions of potential users, this can be huge revenue stream for EKNL

Only 8 Mil free trading shares as of the date of this release.

EKNL also confirmed in their press release a float of just 8 Million shares – solid news and super small float that will make EKNL move xtremely quick.

EKNL closed at $0.086 up 115% on 2.5 Million shares trades and above the key 50 SMA level – with many more updates to follow, expect a monster build to push prices pass all times highs.

ABOUT EKO INTERNATIONAL

EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.

About Xtremepicks.com:
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep informed of the latest movers. Xtremepicks.com penny stock newsletter is the trading connection and remember to always do research, use stop loss orders to protect, and book profits when in a position to do so. Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do own due diligence. Xtremepicks did not receive any compensation for the distribution of this press release. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved.